📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Ruthenium Drug BOLD-100 Regulates BRAF MT Colorectal Cancer Cell Apoptosis through AhR/ROS/ATR Signaling Axis Modulation (2024)

First Author: Griffin D

Attributed to: The Queen’s University of Belfast Confidence in Concept (CiC) programme 2017 funded by UKRI

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1158/1541-7786.mcr-24-0151

Publication URI: http://dx.doi.org/10.1158/1541-7786.mcr-24-0151

Type: Journal Article/Review

Parent Publication: Molecular Cancer Research

Issue: 12